** Shares of biotech firm ONCR.O fall ~14.35% to $17.96
** Co's public offering of 3 mln shares priced at $19.00 per
share, representing a 9.39% discount to stock's close on
Thursday
** Gross proceeds from the offering expected to be $57.0
million urn:newsml:reuters.com:*:nGNX3TkSHl
** ONCR also grants the underwriters a 30-day option to
purchase up to an additional 450,000 shares
** Offering is expected to close on Feb. 17
** Jefferies, Evercore ISI and Piper Sandler are joint
book-running managers for the offering
(Reporting by Rithika Krishna in Bengaluru)
((Rithika.Krishna@thomsonreuters.com;))